M
Marc A. Pfeffer
Researcher at Brigham and Women's Hospital
Publications - 815
Citations - 143710
Marc A. Pfeffer is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Heart failure & Myocardial infarction. The author has an hindex of 166, co-authored 765 publications receiving 133043 citations. Previous affiliations of Marc A. Pfeffer include Partners HealthCare & University of Miami.
Papers
More filters
Journal Article
Modifiable Risk Factors for Stroke in High-Risk Patients following Acute Myocardial Infarction: Insights from the VALIANT Study
UK Sampson,Satish Kenchaiah,Karl Swedberg,Harvey D. White,Yuliya Lokhnygina,Mareev,Ståle Barvik,Gary S. Francis,José Antonio Marin-Neto,Frans Van de Werf,Jean-Lucien Rouleau,Marc A. Pfeffer +11 more
Journal ArticleDOI
Abstract 17975: Anemia in Heart Failure With Preserved Ejection Fraction: Insights From the TOPCAT trial
Eileen O'Meara,Christopher T. Kenwood,Inder S. Anand,Akshay S. Desai,Simon de Denus,Nancy K. Sweitzer,Jerome L. Fleg,Thao Huynh,Sonja M. McKinlay,Bertram Pitt,Marc A. Pfeffer,Jean L. Rouleau +11 more
TL;DR: This data indicates that anemia predicts higher rates of mortality and HF hospitalizations in patients with heart failure (HF) and the factors associated with anemia in TOPCAT, a large running study, are related to mortality and hospitalizations.
Journal ArticleDOI
Effect of single and dual renin-angiotensin blockade on stroke in patients with and without diabetes in VALIANT
Azmil H. Abdul-Rahim,Kieran F. Docherty,Hicham Skali,Lars Køber,Kenneth Dickstein,Aldo P. Maggioni,Viacheslav Mareev,Faiez Zannad,Eric J. Velazquez,Robert M. Califf,Robert M. Califf,Marc A. Pfeffer,Scott D. Solomon,Kenneth R. Lees,John J.V. McMurray +14 more
TL;DR: The risk of stroke after myocardial infarction in patients with diabetes was lower in patients treated with both an angiotensin converting enzyme inhibitor and angiotENSin receptor blocker than in patients receiving either monotherapy.
Weight loss (but not weight gain) is a strong predictor of mortality in chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program
Satish Kenchaiah,John J.V. McMurray,Stuart J. Pocock,Duolao Wang,Scott D. Solomon,Margaret McEntegart,Eric L. Michelson,Christopher B. Granger,Marc A. Pfeffer +8 more
Journal ArticleDOI
Abstract 11159: Prolonged QRS Duration Predicts Outcomes in Heart Failure With Preserved Ejection Fraction
Jacob Joseph,Brian Claggett,Inder S. Anand,Jerome L. Fleg,Thao Huynh,Akshay S. Desai,Scott D. Solomon,Eileen O'Meara,Sonja M. McKinlay,Bertram Pitt,Marc A. Pfeffer,Eldrin F. Lewis +11 more
TL;DR: It is hypothesized that prolonged QRS duration would similarly identify patients with HF with preserved ejection fraction (HFPEF) at high risk for cardiovascular (CV) events.